You are here

Home › Listings › Life Sciences › EXMceuticals Inc.

EXMceuticals Inc.

EXMceuticals Inc.
Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
EXM
CSE Index: 
Currency: 

EXMceuticals (“EXM”) is a bio-science company that strongly believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with the ambition to become one of the world's suppliers of highest-grade cannabis ingredients. EXM is currently creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. EXM has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients to the pharmaceutical, medicinal and wellness industry.

You are here

Home

EXMceuticals Inc. (EXM)

SEDAR Information

Search form

Company Info

Address
421 7th Avenue S.W.
30th Floor
Calgary, AB T2P 4K9
Canada
Phone
587.390.8541
Email
info@exmceuticals.com
Website
https://exmceuticals.com
Listing date
Thursday, January 31, 2019
Transfer Agent
Odyssey Trust Company
Auditor
DMCL LLP

Capitalization

Issued & Outstanding: 
75167510
Reserved for Issuance: 
2809897

Company Officers

Jonathan Summers, Chairman
Michael Kinley, Chief Financial Officer
Julie Lemieux, CEO

News Releases

05/04/2022

EXMceuticals Announces Sale of Portugal Subsidiary

10/01/2022

EXMceuticals Coporate Update

Bulletins

12/12/2023

2023-1219 - Delist - EXMceuticals Inc.(EXM)

le 12 décembre/December 2023

The common shares of EXMceuticals Inc. will be delisted from the CSE at market close on December 12, 2023.

EXMceuticals Inc is currently suspended. See bulletin 2021-1108.

___________________________

CSE Filings

Letter to CSE

Form 6 Certificate of Compliance

FORM 10

Interim Financial Statements - Q3 March31, 2021

Management Discussion and Analysis - Q3 March 31, 2021